Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anna Liza M. Antonio is active.

Publication


Featured researches published by Anna Liza M. Antonio.


Cancer | 2010

Cancer quality-ASSIST supportive oncology quality indicator set feasibility, reliability, and validity testing

Sydney M. Dy; Karl A. Lorenz; Sean M. O'Neill; Steven M. Asch; Anne M. Walling; Diana M. Tisnado; Anna Liza M. Antonio; Jennifer Malin

Although measuring the quality of symptom management and end‐of‐life care could help provide a basis for improving supportive care for advanced cancer, few quality indicators in this area have been rigorously developed or evaluated.


Cancer | 2015

Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer

Jennifer W. Mack; Anne M. Walling; Sydney M. Dy; Anna Liza M. Antonio; John S. Adams; Nancy L. Keating; Diana M. Tisnado

Many patients with incurable cancer inaccurately believe that chemotherapy may cure them. Little is known about how such beliefs affect choices for care at the end of life. This study assessed whether patients with advanced cancer who believed that chemotherapy might offer a cure were more likely to receive chemotherapy in the last month of life and less likely to enroll in hospice care before death.


Journal of Clinical Oncology | 2013

Patient Preference and Contraindications in Measuring Quality of Care: What Do Administrative Data Miss?

Joan J. Ryoo; Diana L. Ordin; Anna Liza M. Antonio; Sabine M. Oishi; Michael K. Gould; Steven M. Asch; Jennifer Malin

PURPOSE Prior studies report that half of patients with lung cancer do not receive guideline-concordant care. With data from a national Veterans Health Administration (VHA) study on quality of care, we sought to determine what proportion of patients refused or had a contraindication to recommended lung cancer therapy. PATIENTS AND METHODS Through medical record abstraction, we evaluated adherence to six quality indicators addressing lung cancer-directed therapy for patients diagnosed within the VHA during 2007 and calculated the proportion of patients receiving, refusing, or having contraindications to recommended treatment. RESULTS Mean age of the predominantly male population was 67.7 years (standard deviation, 9.4 years), and 15% were black. Adherence to quality indicators ranged from 81% for adjuvant chemotherapy to 98% for curative resection; however, many patients met quality indicator criteria without actually receiving recommended therapy by having a refusal (0% to 14%) or contraindication (1% to 30%) documented. Less than 1% of patients refused palliative chemotherapy. Black patients were more likely to refuse or bear a contraindication to surgery even when controlling for comorbidity; race was not associated with refusals or contraindications to other treatments. CONCLUSION Refusals and contraindications are common and may account for previously demonstrated low rates of recommended lung cancer therapy performance at the VHA. Racial disparities in treatment may be explained, in part, by such factors. These results sound a cautionary note for quality measurement that depends on data that do not reflect patient preference or contraindications in conditions where such considerations are important.


JAMA | 2014

Changes in Smoking Prevalences Among Health Care Professionals From 2003 to 2010-2011

Linda Sarna; Stella Aguinaga Bialous; Karabi Nandy; Anna Liza M. Antonio; Qing Yang

Smoking by health care professionals is a barrier to tobacco interventions with patients.1 From 2003 to 2006-2007,2 smoking prevalences among health care professionals demonstrated no significant declines, with the highest prevalence among licensed practical nurses (20.55%) and the lowest prevalence among physicians (2.31%). With the release of 2010-2011 data, we updated these findings to assess changes in smoking status.


Journal of Palliative Medicine | 2011

Quality of Supportive Care for Patients with Advanced Cancer in a VA Medical Center

Jennifer Malin; Sean M. O'Neill; Steven M. Asch; Sydney M. Dy; Anne M. Walling; Diana M. Tisnado; Anna Liza M. Antonio; Karl A. Lorenz

PURPOSE Using the Assessing Symptoms Side Effects and Indicators of Supportive Treatment (ASSIST) quality indicators (QIs), we conducted a comprehensive evaluation of the quality of care provided in our institution to patients diagnosed with advanced cancer in 2006. METHODS Patients diagnosed with a Stage IV solid tumor were identified from the hospitals cancer registry. Using data abstracted from medical records, care was assessed using 41 explicit QIs. Mean percent adherence to QIs was calculated overall, as well as across five clinical domains: (1) Pain, (2) Depression and Psychosocial Distress, (3) Dyspnea, (4) Treatment Toxicity, (5) Other Symptoms, and (6) Information and Care Planning. RESULTS The study cohort (n = 118) was almost all male (2% female) and mean age was 65.9 years (standard deviation [SD] 9.9 years). The most common cancers were lung and head and neck cancer (23% each); 17% had prostate cancer; 13% had colorectal cancer; and the rest (24%) had breast, esophageal, stomach, genitourinary, liver/biliary, or pancreas cancer. Patients received 51% (95% confidence interval [CI] 48%-54%) of recommended care. Adherence to recommended care within domains ranged from 38% (95% CI 35%-42%) for Other Symptoms to 79% (95% CI 73%-86%) for Information and Care Planning. CONCLUSIONS This study suggests that the quality of supportive care for patients with advanced cancer can be greatly improved. Future efforts should use the ASSIST indicators to evaluate the quality of supportive care in larger and more diverse cohorts of advanced cancer patients.


Breast Cancer Research and Treatment | 2010

Predictors of interobserver agreement in breast imaging using the Breast Imaging Reporting and Data System.

Anna Liza M. Antonio; Catherine M. Crespi

The Breast Imaging Reporting and Data System (BI-RADS) was introduced in 1993 to standardize the interpretation of mammograms. Though many studies have assessed the validity of the system, fewer have examined its reliability. Our objective is to identify predictors of reliability as measured by the kappa statistic. We identified studies conducted between 1993 and 2009 which reported kappa values for interpreting mammograms using any edition of BI-RADS. Bivariate and multivariate multilevel analyses were used to examine associations between potential predictors and kappa values. We identified ten eligible studies, which yielded 88 kappa values for the analysis. Potential predictors of kappa included: whether or not the study included negative cases, whether single- or two-view mammograms were used, whether or not mammograms were digital versus screen-film, whether or not the fourth edition of BI-RADS was utilized, the BI-RADS category being evaluated, whether or not readers were trained, whether or not there was an overlap in readers’ professional activities, the number of cases in the study and the country in which the study was conducted. Our best multivariate model identified training, use of two-view mammograms and BI-RADS categories (masses, calcifications, and final assessments) as predictors of kappa. Training, use of two-view mammograms and focusing on mass description may be useful in increasing reliability in mammogram interpretation. Calcification and final assessment descriptors are areas for potential improvement. These findings are important for implementing policies in BI-RADS use before introducing the system in different settings and improving current implementations.


Cancer | 2013

Quality of prostate cancer care among rural men in the Veterans Health Administration.

Ted A. Skolarus; Stephanie Chan; Jeremy Shelton; Anna Liza M. Antonio; Anne Sales; Jennifer Malin; Christopher S. Saigal

Patient travel distances, coupled with variation in facility‐level resources, create barriers for prostate cancer care in the Veterans Health Administration integrated delivery system. For these reasons, the authors investigated the degree to which these barriers impact the quality of prostate cancer care.


Journal of Oncology Practice | 2011

Documentation and Discussion of Preferences for Care Among Patients With Advanced Cancer

Sangeeta C. Ahluwalia; Fukai L. Chuang; Anna Liza M. Antonio; Jennifer Malin; Karl A. Lorenz; Anne M. Walling

PURPOSE We sought to describe the documentation, frequency, and timing of discussions about patient preferences for care and to examine patterns of palliative care and hospice use among patients with advanced cancer. METHODS We prospectively abstracted the medical records of 118 patients receiving care at a Veterans Administration (VA) facility from diagnosis of stage IV disease to 12 months postdiagnosis or death. We used univariate statistics to describe the type and frequency of documentation of patient preferences and palliative care/hospice referral. We calculated the time from diagnosis to the first documentation of preferences and the time from first documentation to death. We compared documentation of patient preferences between decedents and nondecedents using χ(2) tests. RESULTS The majority of patients (81%) had some documentation of their care preferences recorded, although decedents were significantly more likely to have had their preferences documented than nondecedents (96% v 60%; P < .000). Most (53%) patients did not have a formal advance directive documented in the medical record. The mean time from diagnosis to the first documentation of preferences was approximately 2 months. More than half of all patients (53%) and almost three-quarters of decedents (73%) had a palliative care consultation. CONCLUSION Despite high rates of preference documentation, there remains room for improvement. Providers may need to be helped to identify patients earlier in their trajectory for appropriate palliative care services, and future work should focus on developing useful alternatives to advance directives for adequately documenting patient preferences.


Journal of Oncology Practice | 2016

Lower patient ratings of physician communication are associated with unmet need for symptom management in patients with lung and colorectal cancer

Anne M. Walling; Nancy L. Keating; Katherine L. Kahn; Sydney Dy; Jennifer W. Mack; Jennifer Malin; Neeraj K. Arora; John L. Adams; Anna Liza M. Antonio; Diana M. Tisnado

PURPOSE Little is known about factors associated with unmet needs for symptom management in patients with cancer. METHODS Patients with a new diagnosis of lung and colorectal cancer from the diverse nationally representative Cancer Care Outcomes Research and Surveillance cohort completed a survey approximately 5 months after diagnosis (N = 5,422). We estimated the prevalence of unmet need for symptom management, defined as patients who report that they wanted help for at least one common symptom (pain, fatigue, depression, nausea/vomiting, cough, dyspnea, diarrhea) during the 4 weeks before the survey but did not receive it. We identified patient factors associated with unmet need by using logistic regression with random effects to account for clustering within study sites. RESULTS Overall, 15% (791 of 5,422) of patients had at least one unmet need for symptom management. Adjusting for sociodemographic and clinical factors, African American race, being uninsured or poor, having early-stage lung cancer, and the presence of moderate to severe symptoms were associated with unmet need (all P < .05). Furthermore, patients who rated their physicians communication score < 80 (on a 0 to 100 scale) had adjusted rates of an unmet need for symptom management that were more than twice as high as patients who rated their physicians with a perfect communication score (23.1% v 10.0%; P < .001). CONCLUSION A significant minority of patients with newly diagnosed lung and colorectal cancer report unmet needs for symptom management. Interventions to improve symptom management should consider the importance of physician communication to the patients experience of disease.


Community Mental Health Journal | 2017

Impact of a Community-Based Frailty Intervention Among Middle-Aged and Older Prefrail and Frail Homeless Women: A Pilot Randomized Controlled Trial

Benissa E. Salem; Jennifer Ma‐Pham; Stephanie Chen; Mary-Lynn Brecht; Anna Liza M. Antonio; Masha Ames

Interventions are needed to address frailty and other behaviors (e.g., drug and alcohol use) among prefrail and frail homeless women (P/FHW). The purpose of this pilot randomized controlled trial (RCT) was to compare the efficacy of a Frailty Intervention (FI) versus a Health Promotion (HP) program among P/FHW (N = 32). Structured instruments assessed sociodemographics, individual, situational, health-related, and behavioral factors. While program differences were not statistically significant with the main outcome variables, medium-to-large effect sizes were found in favor of the HP program as it relates to physical and overall frailty, as well as, any drug use, alcohol use, and drug dependency. Based on these findings, it is critical to strengthen the HP program to optimize all domains of frailty (e.g., physical, psychological, and social) and substance use for P/FHW.

Collaboration


Dive into the Anna Liza M. Antonio's collaboration.

Top Co-Authors

Avatar

Jennifer Malin

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeremy Shelton

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Diana L. Ordin

Veterans Health Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sydney M. Dy

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge